Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development
Prostate cancer (PCa) is by far the most commonly diagnosed cancer in men worldwide. Despite sensitivity to androgen deprivation, patients with advanced disease eventually develop resistance to therapy and may die of metastatic castration-resistant prostate cancer (mCRPC). A key challenge in the man...
Main Authors: | Hisham F. Bahmad, Mohammad Jalloul, Joseph Azar, Maya M. Moubarak, Tamara Abdul Samad, Deborah Mukherji, Mohamed Al-Sayegh, Wassim Abou-Kheir |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.652747/full |
Similar Items
-
Epidermal Growth Factor Is Essential for the Maintenance of Novel Prostate Epithelial Cells Isolated From Patient-Derived Organoids
by: Katia Cheaito, et al.
Published: (2020-10-01) -
The Effects of Resveratrol on Prostate Cancer through Targeting the Tumor Microenvironment
by: Natalie Silk, et al.
Published: (2021-02-01) -
The Stroma—A Key Regulator in Prostate Function and Malignancy
by: Christina Hägglöf, et al.
Published: (2012-05-01) -
The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
by: Francesco Bonollo, et al.
Published: (2020-07-01) -
Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside
by: Samantha Gogola, et al.
Published: (2023-04-01)